-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Contrasting Tivic Health Systems (NASDAQ:TIVC) and BioLife Solutions (NASDAQ:BLFS)
Contrasting Tivic Health Systems (NASDAQ:TIVC) and BioLife Solutions (NASDAQ:BLFS)
Tivic Health Systems (NASDAQ:TIVC – Get Rating) and BioLife Solutions (NASDAQ:BLFS – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings.
Profitability
This table compares Tivic Health Systems and BioLife Solutions' net margins, return on equity and return on assets.
Get Tivic Health Systems alerts:| Net Margins | Return on Equity | Return on Assets | |
| Tivic Health Systems | -668.17% | -120.72% | -98.51% |
| BioLife Solutions | -67.70% | -7.50% | -6.49% |
Insider and Institutional Ownership
0.2% of Tivic Health Systems shares are owned by institutional investors. Comparatively, 89.8% of BioLife Solutions shares are owned by institutional investors. 14.6% of Tivic Health Systems shares are owned by company insiders. Comparatively, 3.3% of BioLife Solutions shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Analyst Recommendations
This is a summary of current ratings and recommmendations for Tivic Health Systems and BioLife Solutions, as reported by MarketBeat.| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Tivic Health Systems | 0 | 0 | 0 | 0 | N/A |
| BioLife Solutions | 0 | 0 | 1 | 0 | 3.00 |
BioLife Solutions has a consensus target price of $31.20, suggesting a potential upside of 81.82%. Given BioLife Solutions' higher possible upside, analysts clearly believe BioLife Solutions is more favorable than Tivic Health Systems.
Earnings & Valuation
This table compares Tivic Health Systems and BioLife Solutions' revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Tivic Health Systems | $1.17 million | 5.05 | -$8.49 million | N/A | N/A |
| BioLife Solutions | $119.16 million | 6.16 | -$7.64 million | ($2.48) | -6.92 |
BioLife Solutions has higher revenue and earnings than Tivic Health Systems.
Summary
BioLife Solutions beats Tivic Health Systems on 9 of the 10 factors compared between the two stocks.
About Tivic Health Systems
(Get Rating)
Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
About BioLife Solutions
(Get Rating)
BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs, generic blood stem cell freezing and cell thawing media products and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1987 and is headquartered in Bothell, WA.
Receive News & Ratings for Tivic Health Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivic Health Systems and related companies with MarketBeat.com's FREE daily email newsletter.
Tivic Health Systems (NASDAQ:TIVC – Get Rating) and BioLife Solutions (NASDAQ:BLFS – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings.
Tivic Health Systems(纳斯达克：tivc-Get Rating)和BioLife Solutions(纳斯达克：BLFS-GET Rating)都是小盘医疗公司，但哪一家更好？我们将根据这两家公司的盈利能力、机构所有权、估值、股息、风险、分析师建议和收益的强弱进行比较。
Profitability
盈利能力
This table compares Tivic Health Systems and BioLife Solutions' net margins, return on equity and return on assets.
此表比较了Tivic Health Systems和BioLife Solutions的净利润率、股本回报率和资产回报率。
| Net Margins | Return on Equity | Return on Assets | |
| Tivic Health Systems | -668.17% | -120.72% | -98.51% |
| BioLife Solutions | -67.70% | -7.50% | -6.49% |
| 净利润率 | 股本回报率 | 资产回报率 | |
| Tivic Health Systems | -668.17% | -120.72% | -98.51% |
| 生物生命解决方案 | -67.70% | -7.50% | -6.49% |
Insider and Institutional Ownership
内部人与机构持股
0.2% of Tivic Health Systems shares are owned by institutional investors. Comparatively, 89.8% of BioLife Solutions shares are owned by institutional investors. 14.6% of Tivic Health Systems shares are owned by company insiders. Comparatively, 3.3% of BioLife Solutions shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Tivic Health Systems 0.2%的股份由机构投资者持有。相比之下，BioLife Solutions 89.8%的股份由机构投资者持有。Tivic Health Systems 14.6%的股份由公司内部人士持有。相比之下，BioLife Solutions 3.3%的股份由公司内部人士持有。强大的机构持股表明，对冲基金、大型基金管理公司和捐赠基金相信，一只股票的长期表现将好于大盘。
Analyst Recommendations
分析师建议
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Tivic Health Systems | 0 | 0 | 0 | 0 | N/A |
| BioLife Solutions | 0 | 0 | 1 | 0 | 3.00 |
| 销售评级 | 保持评级 | 购买评级 | 强劲的买入评级 | 评级分数 | |
| Tivic Health Systems | 0 | 0 | 0 | 0 | 不适用 |
| 生物生命解决方案 | 0 | 0 | 1 | 0 | 3.00 |
BioLife Solutions has a consensus target price of $31.20, suggesting a potential upside of 81.82%. Given BioLife Solutions' higher possible upside, analysts clearly believe BioLife Solutions is more favorable than Tivic Health Systems.
BioLife Solutions的共识目标价为31.20美元，暗示潜在上涨81.82%。考虑到BioLife Solutions更有可能的上行空间，分析师们显然认为BioLife Solutions比Tivic Health Systems更有利。
Earnings & Valuation
收益与估值
This table compares Tivic Health Systems and BioLife Solutions' revenue, earnings per share and valuation.
此表比较了Tivic Health Systems和BioLife Solutions的收入、每股收益和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Tivic Health Systems | $1.17 million | 5.05 | -$8.49 million | N/A | N/A |
| BioLife Solutions | $119.16 million | 6.16 | -$7.64 million | ($2.48) | -6.92 |
| 总收入 | 价格/销售额比 | 净收入 | 每股收益 | 市盈率 | |
| Tivic Health Systems | 117万美元 | 5.05 | -849万元 | 不适用 | 不适用 |
| 生物生命解决方案 | 1.1916亿美元 | 6.16 | -764万元 | ($2.48) | -6.92 |
BioLife Solutions has higher revenue and earnings than Tivic Health Systems.
BioLife Solutions的收入和收益高于Tivic Health Systems。
Summary
摘要
BioLife Solutions beats Tivic Health Systems on 9 of the 10 factors compared between the two stocks.
BioLife Solutions在两只股票比较的10个因素中有9个击败了Tivic Health Systems。
About Tivic Health Systems
关于Tivic Health Systems
(Get Rating)
(获取评级)
Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
Tivic Health Systems Inc.是一家生物电子设备公司，提供用于治疗炎症情况的非侵入性神经调节产品。它的主要产品是Clearup，是一种旨在缓解鼻窦和鼻部炎症的医疗设备。该公司通过自己的网站、亚马逊(Amazon.com)和沃尔玛(Walmart.com)等平台以及BestBuy.com和FSAStore.com等美国在线零售商，通过直接面向消费者的渠道销售产品。Tivic Health Systems，Inc.成立于2016年，总部设在加利福尼亚州海沃德。
About BioLife Solutions
关于BioLife解决方案
(Get Rating)
(获取评级)
BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs, generic blood stem cell freezing and cell thawing media products and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1987 and is headquartered in Bothell, WA.
BioLife Solutions，Inc.致力于细胞和组织生物保存工具的开发、制造和营销。其产品包括用于细胞、组织和器官的专有低温储存和冷冻保存冷冻介质产品，通用血液干细胞冷冻和细胞解冻介质产品，以及定制产品配方和定制包装服务。该公司由鲍里斯·鲁宾斯基于1987年创立，总部设在华盛顿州博塞尔。
Receive News & Ratings for Tivic Health Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivic Health Systems and related companies with MarketBeat.com's FREE daily email newsletter.
接受Tivic Health Systems Daily的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Tivic Health Systems和相关公司的最新新闻和分析师评级的每日简明摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧